Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|July 2, 2021
Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat DietMichael Ezrokhi, Yahong Zhang, Shuqin Luo, et al.
Diabetology & Metabolic Syndrome|May 5, 2015
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsMichael Ezrokhi, Shuqin Luo, Yelena Trubitsyna, et al.
Diabetology & Metabolic Syndrome|August 15, 2015
Erratum: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsMichael Ezrokhi, Shuqin Luo, Yelena Trubitsyna, et al.
Postgraduate Medicine|October 1, 2016
Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metforminBindu Chamarthi, Michael Ezrokhi, Dean Rutty, et al.
Endocrinology, Diabetes & Metabolism|January 11, 2020
Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitusBindu Chamarthi, Aaron Vinik, Michael Ezrokhi, et al.
Molecular and Cellular Biology|November 26, 2002
Developmental changes in the Sciara II/9A initiation zone for DNA replicationVictoria V Lunyak, Michael Ezrokhi, Heidi S Smith, et al.
Neuroendocrinology|December 21, 2023
Tyrosine Hydroxylase Knockdown at the Hypothalamic Supramammillary Nucleus Area Induces Obesity and Glucose IntoleranceYahong Zhang, Tsung-Huang Tsai, Michael Ezrokhi, et al.
BMC Endocrine Disorders|June 27, 2007
A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset or placeboRichard E Scranton, J Michael Gaziano, Dean Rutty, et al.
Neuroscience|May 15, 2021
Activation State of the Supramammillary Nucleus Regulates Body Composition and Peripheral Fuel MetabolismYahong Zhang, Carl Stoelzel, Michael Ezrokhi, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agentsAaron I Vinik, Anthony H Cincotta, Richard E Scranton, et al.
Pageof 2